Oragenics Inc.

AMEX: OGEN · Real-Time Price · USD
1.14
-0.05 (-4.20%)
At close: Aug 15, 2025, 3:59 PM
1.17
2.61%
After-hours: Aug 15, 2025, 07:37 PM EDT

Oragenics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
864.84K 3.48M 11.43M 27.27M
Short-Term Investments
n/a n/a 17.94K n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a 1.09M n/a n/a
Receivables
n/a n/a n/a 6.99K
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
1.47M 3.87M 14.29M 27.71M
Property-Plant & Equipment
n/a 9.81K 468.5K 523.59K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
n/a 1.1M 468.5K 523.59K
Total Assets
1.47M 4.97M 14.76M 28.23M
Account Payables
1.14M 1.24M 246.69K 854.98K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
328.53K 312.7K 267.64K 303.42K
Other Current Liabilities
202.83K n/a 843.96K 57.73K
Total Current Liabilities
1.68M 1.8M 1.6M 1.45M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a 152.44K 299.52K
Total Liabilities
1.68M 1.8M 1.75M 1.74M
Total Debt
328.53K 322.51K 624.53K 797.21K
Common Stock
12.57K 3.08K 2.02K 116.39K
Retained Earnings
-216.79M -206.22M -185.56M -171.27M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
-211.88K 3.17M 13.01M 26.49M
Total Investments
n/a n/a 17.94K n/a